Cbx7 acts as tumor inhibitor and is significantly downregulated in bladder [55], breast [56], liver [57], colon [58], thyroid [59], glioma [60], and pancreatic cancers [61]. This evidence concerns the gene CBX7 and familial pancreatic carcinoma.